NCT03126435 2023-05-06EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOXSynCore Biotechnology Co., Ltd.Phase 3 Completed218 enrolled 19 charts
NCT03002103 2023-04-26A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast CancerSynCore Biotechnology Co., Ltd.Phase 3 Suspended420 enrolled